THE Zambia Medicines Regulatory Authority (ZAMRA) says it has instituted investigations to establish the cause of defects in the recalled Cevite Tablets.

In a statement, Monday, ZAMRA senior public relations officer Christabel LLiamupu said the Authority had quarantined all batches of Cevite Tablets at Shalina Pharmaceuticals Limited.

ZAMRA encouraged members of the public to report any products which might be exhibiting signs of deterioration for further investigation.

“THE Zambia Medicines Regulatory Authority (ZAMRA) wishes to inform members of the public that the Authority has instituted investigations to establish the cause of the defects in the recalled Cevite Tablets. Bearing batch numbers 0371572 and 0372251 that was imported by Shalina Pharmaceuticals (Z) Limited, Further, we wish to advise that quality analysis of the products is ongoing and the public will be informed of the outcome in due course,” stated LLiamupu.

“The Authority has since quarantined all batches of Cevite Tablets at Shalina Pharmaceuticals Limited and is in constant communication with the company to monitor the recall process. Members of the public are advised to report products which may be exhibiting signs of deterioration to the Authority for further investigations and appropriate regulatory action. In this regard, the Authority further wishes to call upon all license holders to adhere to Good Distribution Practices (GDP) and monitor products in their possession at all times.”